Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 942

Similar articles for PubMed (Select 18401285)

1.

Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss.

Battaglia A, Burchette R, Cueva R.

Otol Neurotol. 2008 Jun;29(4):453-60. doi: 10.1097/MAO.0b013e318168da7a.

PMID:
18401285
2.

Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.

Haynes DS, O'Malley M, Cohen S, Watford K, Labadie RF.

Laryngoscope. 2007 Jan;117(1):3-15. Review.

PMID:
17202923
3.

A prospective, multi-centered study of the treatment of idiopathic sudden sensorineural hearing loss with combination therapy versus high-dose prednisone alone: a 139 patient follow-up.

Battaglia A, Lualhati A, Lin H, Burchette R, Cueva R.

Otol Neurotol. 2014 Jul;35(6):1091-8. doi: 10.1097/MAO.0000000000000450.

PMID:
24892363
4.

Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy.

Plontke SK, Löwenheim H, Mertens J, Engel C, Meisner C, Weidner A, Zimmermann R, Preyer S, Koitschev A, Zenner HP.

Laryngoscope. 2009 Feb;119(2):359-69. doi: 10.1002/lary.20074.

PMID:
19172627
5.

Effectiveness of intratympanic dexamethasone injection in sudden-deafness patients as salvage treatment.

Ho HG, Lin HC, Shu MT, Yang CC, Tsai HT.

Laryngoscope. 2004 Jul;114(7):1184-9.

PMID:
15235345
6.

The treatment of idiopathic sudden sensorineural hearing loss using pulse therapy: a prospective, randomized, double-blind clinical trial.

Westerlaken BO, de Kleine E, van der Laan B, Albers F.

Laryngoscope. 2007 Apr;117(4):684-90.

PMID:
17415139
7.

Comparison of intratympanic and intravenous dexamethasone treatment on sudden sensorineural hearing loss with diabetes.

Kakehata S, Sasaki A, Oji K, Futai K, Ota S, Makinae K, Shinkawa H.

Otol Neurotol. 2006 Aug;27(5):604-8.

PMID:
16788418
8.

Intratympanic steroid injections as a salvage treatment for sudden sensorineural hearing loss: a randomized, double-blind, placebo-controlled study.

Wu HP, Chou YF, Yu SH, Wang CP, Hsu CJ, Chen PR.

Otol Neurotol. 2011 Jul;32(5):774-9. doi: 10.1097/MAO.0b013e31821fbdd1.

PMID:
21646929
9.

Modified intratympanic treatment for idiopathic sudden sensorineural hearing loss.

Kara E, Cetik F, Tarkan O, Sürmelioğlu O.

Eur Arch Otorhinolaryngol. 2010 May;267(5):701-7. doi: 10.1007/s00405-009-1130-5. Epub 2009 Oct 28.

PMID:
19862543
10.

Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study.

Xenellis J, Papadimitriou N, Nikolopoulos T, Maragoudakis P, Segas J, Tzagaroulakis A, Ferekidis E.

Otolaryngol Head Neck Surg. 2006 Jun;134(6):940-5.

PMID:
16730534
11.

Error occurred: cannot get document summary

PMID:
25719121

12.

Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and Ménière's-associated sudden sensorineural hearing loss.

Selivanova OA, Gouveris H, Victor A, Amedee RG, Mann W.

Otol Neurotol. 2005 Sep;26(5):890-5.

PMID:
16151334
13.

Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy.

Plaza G, Herráiz C.

Otolaryngol Head Neck Surg. 2007 Jul;137(1):74-8.

PMID:
17599569
14.

Intratympanic dexamethasone for profound idiopathic sudden sensorineural hearing loss.

Battista RA.

Otolaryngol Head Neck Surg. 2005 Jun;132(6):902-5.

PMID:
15944562
15.
16.

Outcomes research analysis of continuous intratympanic glucocorticoid delivery in patients with acute severe to profound hearing loss: basis for planning randomized controlled trials.

Plontke S, Löwenheim H, Preyer S, Leins P, Dietz K, Koitschev A, Zimmermann R, Zenner HP.

Acta Otolaryngol. 2005 Aug;125(8):830-9.

PMID:
16158529
17.

Intratympanic and systemic steroids for sudden hearing loss.

Koltsidopoulos P, Bibas A, Sismanis A, Tzonou A, Seggas I.

Otol Neurotol. 2013 Jun;34(4):771-6. doi: 10.1097/MAO.0b013e31828bb567.

PMID:
23652330
18.

Intratympanic dexamethasone/hyaluronic acid mix as an adjunct to intravenous steroid and vasoactive treatment in patients with severe idiopathic sudden sensorineural hearing loss.

Gouveris H, Schuler-Schmidt W, Mewes T, Mann W.

Otol Neurotol. 2011 Jul;32(5):756-60. doi: 10.1097/MAO.0b013e31821a3fc3.

PMID:
21646933
19.

[The effect of intratympanic dexamethasone or methylprednisolone on treatment of sudden sensorineural hearing loss].

Yang J, Huang L, Shi J, Li Y, Wu H, Kong W.

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2010 Jul;24(13):594-7. Chinese.

PMID:
20842947
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk